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Abstract
Introduction: Previous studies have indicated that transforming growth factor b (TGF-b) signaling has a critical role
in cartilage homeostasis and repair, yet the mechanisms of TGF-b’s chondroprotective effects are not known. Our
objective in this study was to identify downstream targets of TGF-b that could act to maintain biochemical and
biomechanical properties of cartilage.
Methods: Tibial joints from 20-week-old mice that express a dominant-negative mutation of the TGF-b type II
receptor (DNIIR) were graded histologically for osteoarthritic changes and tested by indentation to evaluate their
mechanical properties. To identify gene targets of TGF-b, microarray analysis was performed using bovine articular
chondrocytes grown in micromass culture that were either treated with TGF-b or left untreated. Phosphoadenosine
phosphosynthetase 2 (PAPSS2) was identified as a TGF-b-responsive gene. Papss2 expression is crucial for proper
sulfation of cartilage matrix, and its deficiency causes skeletal defects in mice and humans that overlap with those
seen in mice with mutations in TGF-b-signaling genes. Regulation of Papss2 was verified by real time RT-PCR and
Western blot analyses. Alterations in sulfation of glycosaminoglycans were analyzed by critical electrolyte
concentration and Alcian blue staining and immunofluorescence for chondroitin-4-sulfate, unsulfated chondroitin
and the aggrecan core protein.
Results: DNIIR mutants showed reduced mechanical properties and osteoarthritis-like changes when compared to
wild-type control mice. Microarray analysis identified a group of genes encoding matrix-modifying enzymes that
were regulated by TGF-b. Papss2 was upregulated in bovine articular chondrocytes after treatment with TGF-b and
downregulated in cartilage from DNIIR mice. Articular cartilage in DNIIR mice demonstrated reduced Alcian blue
staining at critical electrolyte concentrations and reduced chondroitin-4-sulfate staining. Staining for unsulfated
chondroitin sulfate was increased, whereas staining for the aggrecan core protein was comparable in DNIIR and
wild-type mice.
Conclusion: TGF-b maintains biomechanical properties and regulates expression of Papss2 and sulfation of
glycosaminoglycans in mouse articular cartilage.
* Correspondence: rserra@uab.edu
2Department of Cell Biology, University of Alabama at Birmingham, 1530 3rd
Avenue South, Birmingham, AL 35294-0005, USA
Full list of author information is available at the end of the article
Ramaswamy et al. Arthritis Research & Therapy 2012, 14:R49
http://arthritis-research.com/content/14/2/R49
© 2012 Ramaswamy et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Introduction
Osteoarthritis (OA) is the most common form of arthri-
tis and a major cause of disability worldwide. OA is pri-
marily a disease that affects articular cartilage, the
permanent cartilage present on surfaces of diarthrodial
joints. It is important for smooth functioning and load
transfer across the joints. Chondrocytes respond to a
variety of stimuli, including mechanical loading and
growth factors that maintain cartilage homeostasis. Type
II collagen and proteoglycans, primarily aggrecan, are
the major constituents of the extracellular matrix
(ECM), which form a meshwork that acts as the main
load-bearing component of the cartilage [1].
The transforming growth factor b (TGF-b) superfam-
ily is known to play an important role in the skeletal
system, especially in the development and maintenance
of growth plate and articular cartilage [2,3]. Altered sig-
naling and reduced expression of TGF-b ligands and
receptors have been associated with OA in both mice
and humans [4,5]. Previously, it was shown that mice
expressing a dominant-negative mutation of the TGF-b
type II receptor (DNIIR) in the cartilage have OA-like
symptoms, including increased hypertrophy, chondro-
cyte clustering and osteophytes in the joint space [6].
Similar results were previously shown using mouse
models with alterations in other components of TGF-b
signaling, including Smad3, LTBP3 and Smurf2 [7-9].
None of these studies characterized the changes in bio-
mechanical properties of articular cartilage during joint
degeneration, however, and the mechanisms of TGF-b’s
chondroprotective effects are still not known.
Biomechanical integrity is critical for healthy function-
ing of the joints. Changes in extracellular and pericellu-
lar matrix, water content and fixed-charge density are
significant features of OA and are known to affect the
mechanical properties of cartilage [10-12]. Cartilage
matrix contains high concentrations of negatively
charged sulfate and carboxyl groups that help attract
and retain water during loading [13]. Sulfation is an
essential posttranslational modification in which sulfate
groups are added to glycosaminoglycan chains that are
covalently linked to core proteins of proteoglycans. 3’-
Phosphoadenosine 5’-phosphosulfate synthetase 2
(Papss2) is a bifunctional enzyme that catalyzes the
synthesis of 3’-phosphoadenosine-5’-phosphosulfate
(PAPS), the universal sulfate donor for all sulfotransfer-
ase reactions [14,15]. Mutations in PAPSS2 cause an
autosomal recessive form of spondyloepimetaphyseal
dysplasia (SEMD), Pakistani type [OMIM:612847], in
humans, whereas a point mutation in the adenosine 5’-
phosphosulfate kinase region of Papss2 causes brachy-
morphism (bm) in mice [16-19]. Both conditions are
characterized by short stature, kyphoscoliosis and
premature joint degeneration that resemble some of the
phenotypic features of mice with altered TGF-b signal-
ing [6,17,19-21]. Factors that regulate Papss2 expression
are unknown.
The goal in this study was to identify downstream tar-
gets of TGF-b that act to maintain biochemical and bio-
mechanical properties of cartilage. We identified
PAPSS2 as a TGF-b-regulated gene in bovine articular
cartilage. We subsequently showed that Papss2 and the
level of chondroitin 4-sulfate are downregulated in
DNIIR cartilage, whereas levels of the aggrecan core
protein are comparable with those of control mice. We
hypothesize that altered TGF-b signaling and the result-
ing changes in Papss2 expression and matrix sulfation
adversely affect the mechanical properties of the carti-
lage, leading to joint degeneration.
Materials and methods
DNIIR mice
All mice in this study were maintained and handled
with the approval of the Institutional Animal Care and
Use Committee of the University of Alabama at Bir-
mingham. Generation of transgenic mice expressing a
cytoplasmic truncated, functionally inactive DNIIR
under the control of a metallothionein-like promoter
was described previously. Mice were genotyped by PCR
with DNA extracted from mice tails. The primer
sequences for genotyping were described previously [6].
Mechanical testing
The mice were killed at 12 or 20 weeks of age, and right
tibiae were extracted and stored at 4°C in PBS until
tested. Mechanical testing was done within 48 hours of
tissue extraction. Articular cartilage was tested by inden-
tation on a computer-controlled electromechanical test
system (Bose LM1 ElectroForce TestBench; Bose Corp,
Eden Prairie, MN, USA) fitted with a 250-g load cell
(Sensotec Honeywell, Columbus, OH, USA). The tibiae
were cut with a surgical blade at 6 mm measured from
the articular cartilage surface, embedded in polymethyl-
methacrylate, mounted in a custom-made specimen
chamber, immersed in PBS and maintained at room
temperature. The articular surface was maintained wet
with PBS during the embedding process. The specimen
chamber was fixed on a custom-made X-Y stage with
micrometer control and a 360° rotating arm (Figure 1A).
A four-step stress relaxation test was performed on
each specimen utilizing a custom-made cylindrical,
impervious, plane-ended indenter (178-μm diameter)
positioned perpendicular to the cartilage surface with
the use of a stereomicroscope. Indentation was per-
formed on the lateral tibial plateau. The indenter was
positioned approximately at the central region of the
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tibial surface with respect to the mediolateral and dor-
soventral axes. Indentation was performed consistently
at the same location by viewing it through a stereomi-
croscope and adjusting the sample by moving the X-Y
stage so that the indenter was on top of the central
region of the lateral tibial plateau. Initially, a tare load
of 0.05 g was applied and the cartilage was allowed
200 seconds to reach equilibrium. The cartilage surface
was then displaced by 20 μm over four steps of 5 μm
each with a relaxation time of 200 seconds between
every step (Figure 1B). Load values measured immedi-
ately after every displacement step and at the end of
every 200-second equilibrium period were converted to
stress values by dividing the load by the indenter sur-
face area, and strain values were calculated using the
ratio of displacement steps to cartilage thickness
[10,22]. Stress-strain curves were plotted separately for
both instantaneous and equilibrium values. Stiffness
was determined as the slope of the respective curves
and called instantaneous and equilibrium stiffness,
respectively. After stress relaxation was complete, the
load was removed and the cartilage was allowed to
return to its original shape. The indenter was replaced
with a sharp tungsten needle (1-μm tip radius) that
was pushed through the cartilage surface to measure
cartilage thickness as indicated by changes noted in
the load-displacement curve at the surface and tide-
mark [23].
Histology
Tibiae from mice were fixed in 4% paraformaldehyde
overnight, decalcified, processed in ethanol solutions
and embedded in paraffin. Sections 6 μm thick were cut
and mounted on Superfrost Plus slides (Fisher Scientific,
Pittsburgh, PA, USA). Sections were stained with H &
E, toluidine blue and Sirius red as described previously
[24]. Sections were stained employing the critical elec-
trolyte concentration principle with 0.05% Alcian blue
8GX (Electron Microscopy Sciences, Hatfield, PA, USA)
in 0.025 M sodium acetate buffer at pH 5.8 and 0.5 M
MgCl2 overnight and were counterstained with nuclear
fast red [25,26].
Figure 1 Mechanical properties of articular cartilage. (A) Schematic of indentation testing setup. (a) 360° rotating arm. (b) Specimen
chamber filled with PBS. (c) 250-g load cell with indenter. (B) Representative four-step stress relaxation curve with 5-μm displacement steps and
200-second relaxation time between each step. (C) Indentation results for control and dominant-negative transforming growth factor b type II
receptor (DNIIR) tibiae at ages 12 weeks (n = 3 controls and 3 DNIIR) and 20 weeks (n = 7 controls and 6 DNIIR). Significant changes in stiffness
were not observed in DNIIR cartilage at 12 weeks. Instantaneous and equilibrium stiffness were significantly lower in DNIIR cartilage at 20 weeks.
In control mice, stiffness increased significantly between ages 12 and 20 weeks. Stiffness was not significantly changed for DNIIR mice over the
same time period. (D) Articular cartilage thickness was significantly reduced in DNIIR mutants as compared to age-matched controls at 20 weeks
of age, but no difference was observed at 12 weeks. Values are means ± SD. *P < 0.05.
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Bovine micromass cultures
Bovine metacarpal-phalangeal joints were obtained from
a local abattoir. Cultures were set up according to a pro-
tocol described previously [27,28]. Briefly, full-thickness
slices of cartilage were taken off the bone and placed
into DMEM/10% fetal bovine serum (FBS) containing
antibiotics and fungicide. The tissue was then minced
finely and placed into DMEM/10% FBS containing 0.2%
collagenase overnight. The isolated cells were removed,
washed, strained and resuspended in fresh DMEM/10%
FBS at a concentration of 2 × 107 cells/ml. Twenty-
microliter drops were placed into the bottom of each
well of a 24-well plate. The cells were allowed to adhere
to each other and to the plate for 3 hours, then the well
was flooded with 1 ml of DMEM/0.5% FBS, ascorbate
and antibiotics.
Alcian blue staining was quantified as the absorbance
at 595 nm of the guanidine-extracted stain over the
quantity of DNA measured by the fluorescence of
Hoechst dye [29]. Cells were washed, stained with
0.125% Alcian blue in 0.1 M HCl overnight at 37°C,
washed and extracted in 6 M guanidine hydrochloride.
Alkaline phosphatase activity was quantified as nanomo-
lar p-nitophenol released per hour over the amount of
DNA.
Affymetrix microarrays
RNA was isolated from bovine cells grown in micromass
culture either untreated or treated with 5 ng/ml TGF-b1
(R&D Systems, Minneapolis, MN, USA) for 8 hours
using TRIzol reagent (Invitrogen, Carlsbad, CA, USA).
The Affymetrix GeneChip Bovine Genome Array (Affy-
metrix, Inc, Santa Clara, CA, USA) was completed in
the Gene Expression Shared Facility located in the
Heflin Center for Genomic Sciences at the University of
Alabama at Birmingham. The quality of each RNA sam-
ple was determined by analysis on the 2100 Agilent
Bioanalyzer (Agilent Technologies, Inc, Santa Clara, CA,
USA) prior to RNA labeling. Detailed GeneChip analyti-
cal procedures are presented in the Manufacturer’s Gen-
eChip Expression Technical Manual (Affymetrix).
Briefly, 50 ng of total RNA from each sample were used
in a two-cycle cDNA amplification protocol using T7-
linked oligo(dT) primers according to the manufac-
turer’s instructions. After the first round of cDNA
synthesis, an in vitro transcription step was utilized to
amplify the RNA, following which a second round of
cDNA synthesis was performed. Subsequently, cRNA
was generated and biotin was incorporated into the
cRNA strand using standard methods (Affymetrix), fol-
lowed by cRNA fragmentation and preparation of hybri-
dization cocktail. The arrays were hybridized overnight
at 45°C, then washed, stained and scanned the next day.
Gene expression levels were extracted using the Affyme-
trix GeneChip Command Console (AGCC; Affymetrix).
Statistical analysis and gene lists for the array experi-
ments were generated using the GeneSpring software
package (Agilent Technologies). Briefly, to generate gene
lists, the raw GeneChip files (.cel) from GeneChip Oper-
ating Software (AGCC) were uploaded to GeneSpring,
background was subtracted and data were normalized
using the Robust Multichip Average method and default
settings in GeneSpring. The untreated control group
was used as a baseline to calculate the intensity ratio or
fold changes of the TGF-b-treated versus control
groups. The ratio was log2-transformed before further
statistical analysis. The P-values were calculated by t-
test assuming unequal variance. Microarray data were
deposited into the Gene Expression Omnibus database
[GEO:GSE29233].
Real-time RT-PCR
RNA from bovine cultures was used for real-time RT-
PCR to confirm the array results. To verify regulation in
DNIIR mice, RNA was isolated from articular cartilage
from wild-type (WT) and DNIIR mice. First, articular
cartilage was carefully dissected from forelimb and hind
limb joints and digested in 3 mg/ml collagenase D for 3
hours at 37°C, and cells were isolated from the matrix.
RNA was extracted from the cells using TRIzol reagent
(Invitrogen). RNA was DNase-treated (Promega, Madi-
son, WI, USA), and real-time RT-PCR was performed
using the SYBR Green RT-PCR Kit (QIAGEN, Valencia,
CA, USA) on the LightCycler 480 Real-Time PCR Sys-
tem (Roche Applied Science, Indianapolis, IN, USA).
Changes in expression levels of bovine or mouse Prg4,
Papss2, and Plod2 were determined using hypoxanthine
ribosyltransferase (Hprt) as the normalization gene in
mouse samples and glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) in bovine samples. Primers that
crossed intron boundaries were either designed or
selected from PrimerBank http://pga.mgh.harvard.edu/
primerbank/. The sequences are listed in Table 1. The
results were analyzed using REST software [30].
Western blot analysis
Articular cartilage from forelimb and hind limb joints of
6 week, 20 week, and 10 month old control and DNIIR
mice was digested for 3 hours in 3 mg/ml collagenase D
(Roche Applied Science) dissolved in DMEM/F-12 nutri-
ent mixture (Gibco/Life Technologies, Grand Island,
NY, USA) at 37°C in a thermal incubator. The digest
was filtered through a 40-μm cell strainer. After centri-
fugation, the pellet was lysed in TRIzol reagent (Invitro-
gen) and both RNA and protein were extracted
according to the manufacturer’s instructions. Equal
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amounts of protein samples from the cell lysate were
separated by reducing electrophoresis with 10% acryla-
mide gels. After transfer to polyvinylidene fluoride
membrane (Bio-Rad Laboratories, Hercules, CA, USA),
the membranes were blocked with 5% nonfat dry milk
and incubated with monoclonal antibody to Papss2
(1:1,000 dilution; Sigma-Aldrich, St Louis, MO, USA).
Blots were then incubated with horseradish peroxidase-
conjugated goat anti-mouse immunoglobulin G (IgG)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Immunoblots were developed by chemiluminescence
(Thermo Fisher Scientific). Gapdh was used as a loading
control. The blots were scanned using an Epson Perfec-
tion V700 photo scanner (Epson America Inc, Long
Beach, CA, USA) at 1,200 dpi, then densitometry was
measured using KODAK molecular imaging software
(Eastman Kodak, Rochester, NY, USA).
Immunofluorescence
Paraffin-embedded tibial sections from 20-week-old
mice were dewaxed and hydrated. Antigen unmasking
was performed by incubating sections in 0.1% trypsin
(Sigma-Aldrich) in 1 × PBS at 37°C for 12 minutes. Sec-
tions were treated with chondroitinase ABC (Sigma-
Aldrich) for 1 hour at 37°C. The Mouse on Mouse (M.
O.M.) Immunodetection Kit (Vector Laboratories, Bur-
lingame, CA, USA) was then used with mouse primary
antibodies, and immunofluorescence was performed
according to the manufacturer’s instructions. Sections
were stained with anti-chondroitin-4-sulfate (C4S) (2-B-
6) and anti-chondroitin-0-sulfate (C0S) (1-B-5) (Seika-
gaku Corp, Tokyo, Japan) at 1:400 dilution. Biotinylated
anti-mouse IgG secondary antibody, followed by Cy3-
conjugated streptavidin, was applied to the sections. Sec-
tions without chondroitinase treatment were included
for antibody specificity. For aggrecan, after antigen-
unmasking sections were blocked with 5% BSA and 5%
goat serum in Tris-buffered saline with 0.1% Tween 20
and incubated with anti-rabbit aggrecan antibody
(AB1031; Millipore, Billerica, MA, USA), and Alexa
Fluor 488-conjugated anti-rabbit secondary antibody
was used for fluorescence. Sections without primary
antibody were included for antibody specificity.
Statistical analysis
Indentation test results were assessed by analysis of var-
iance to compare 12- and 20-week control and mutant
samples. P < 0.05 was considered statistically significant.
Real-time RT-PCR data were analyzed using REST soft-
ware [30], which enables statistical comparison of differ-
ent genes between multiple groups. Instead of applying
a parametric test, REST software performs randomiza-
tion tests (at least 2,000 randomizations) on groupwise
data and calculates expression ratios of target genes
compared to a reference gene along with the P-values.
Differences were considered significant at P < 0.05.
Results
Mechanical properties of articular cartilage in control and
DNIIR mice
Previously, we showed that dominant-negative interfer-
ence of Tgfbr2 (DNIIR) in mice results in OA-like
symptoms in the peripheral joints [6]. To characterize
any TGF-b-mediated alterations in the mechanical prop-
erties of articular cartilage in mice, a four-step stress-
relaxation-indentation test was performed on the tibial
plateau of 12- and 20-week-old WT control and DNIIR
mice (Figures 1A and 1B). No significant differences in
stiffness or cartilage thickness were observed between
WT and DNIIR mice at 12 weeks of age (Figures 1C
and 1D). In contrast, both instantaneous and equili-
brium stiffness were significantly reduced (about 35%, P
< 0.05) (Figure 1C) in 20-week-old mutant mice com-
pared to age-matched WT controls. In addition, stiffness
was significantly increased in control mice between 12
and 20 weeks of age; however, the increase in DNIIR
mice between ages 12 and 20 weeks was much less and
not significant (Figure 1C). Articular cartilage thickness
Table 1 Primer sequences used in real-time RT-PCR
Gene Forward primer Reverse primer
Mouse
Hprt TCA GTC AAC GGG GGA CAT AAA GGG GCT GTA CTG CTT AAC CAG
Prg4 GAA AAT ACT TCC CGT CTG CTT GT ACT CCA TGT AGT GCT GAC AGT TA
Papss2 CCC GTG ATG GAG TCA TCA ACA TGA G GTG CTT TGC AGT GGC TGT TCC
Plod2 CAC TGG ATT ATC CCA AAG AAG CCC CCT GGC TTC TGC TTG ACT TAG GTT
Fxyd2 ATC CCT TCG AGT ACG ACT ATG AA CAG CGG AAC CTT TTG CTG AGA
Bovine
Gapdh GGG TCA TCA TCT CTG CAC CT GGT CAT AAG TCC CTC CAC GA
Prg4 TGC CCT GAC TTC AAG AAG GAA TGC CCA TAA TCG GAA CAG CAC TTG CCA
Papss2 TGC CAT CTT CCC ATC TCC CAT GTT ACA GGT CTC TCT TGG TCT CAG GAT
Plod2 CCC TTT CCT ACC TCG ATT TCT GAA CAC CCA TGT TTC TGG CTT CAG CTT GAC
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as measured by the needle probe method showed that
mutants also possessed thinner articular cartilage (about
17%, P < 0.05) (Figure 1D) relative to controls at 20
weeks of age. The structural stiffness results should not
be affected by this small change in cartilage thickness,
because stiffness is calculated as the slope of the stress-
strain curve, where strain is the change in cartilage
thickness divided by the original thickness. The results
suggest that alterations in TGF-b signaling adversely
affect the mechanical properties of articular cartilage in
mice.
To determine the severity of OA in the mice tested,
we took sections of the contralateral tibiae from a subset
of 20-week-old mice (n = 3 control and 3 DNIIR) and
stained them with H & E to determine the basic histol-
ogy of the tissue, with toluidine blue to determine the
level of proteoglycan matrix depletion and with Sirius
Red by polarized light microscopy to determine the level
of collagen organization (Figure 2). The cartilage exhib-
ited matrix discontinuity at the superficial layer to shal-
low vertical fissures by H & E staining (Figures 2A and
2B). Loss of toluidine blue staining was focal but went
deep into the cartilage (Figures 2C and 2D). Clustering
of chondrocytes was evident in the top layers of the car-
tilage. Collagen fibers were disorganized, and there was
an increase in collagen staining suggestive of new col-
lagen formation (Figures 2E and 2F). To determine the
extent of OA in the mutant mice, we used the scoring
system described by Pritzker et al. [31]. In this system,
grade describes the depth of OA and stage describes
how much of the surface is involved. The final score is
calculated as grade time stage. Because more than 50%
of the cartilage surface was involved in 20-week-old
DNIIR mice, the stage was 4.0. The grades of DNIIR
mice at the same age were 2.0 to 3.0, so the scores for
20-week-old DNIIR mice were 8.0 to 12.0. The score for
WT mice was 0. The extent of OA in these mice was
less severe than previously reported [6], likely due to a
selective advantage for breeding in mice with less severe
OA.
Matrix-modifying genes are regulated by TGF-b in
articular cartilage
The data above and previous results suggest that TGF-b
normally prevents joint degeneration; however, the
downstream effectors of TGF-b in the articular cartilage
are not known [6-9]. To identify genes that are likely
direct targets of TGF-b in the articular cartilage, we
used bovine articular chondrocytes grown in micromass
culture [27,28]. This strategy has the advantages over
dissecting tissue from mice that there is less contamina-
tion with other cell types and the genes identified are
more likely to be directly regulated by TGF-b. The effect
of TGF-b on the phenotype of the chondrocytes in
culture was tested first (Figures 3A through 3D). Cells
were treated with 5 ng/ml TGF-b1 for 7 days. Standard
Alcian blue staining was used as a measure of overall
proteoglycan content (Figures 3A and 3B). The level of
staining was then quantified by absorbance at 595 nm
(Figure 3E). Alkaline phosphatase staining (Figures 3C,
D and 3F) was used as a measure of late hypertrophic
differentiation. Treatment with TGF-b resulted in
increased Alcian blue staining and decreased alkaline
phosphatase activity, indicating that TGF-b is active in
this model. This is consistent with data previously
reported for bovine articular chondrocytes treated with
TGF-b [28].
Next, RNA was isolated from cells untreated or trea-
ted with 5 ng/ml TGF-b1 for 8 hours. Microarray ana-
lysis was done using Affymetrix GeneChip Bovine
Genome Array GeneChips, which contain 24,072 probe
sets representing approximately 23,000 bovine genes.
Micromass cultures of articular cartilage from three
separate cows were grown in the presence or absence
of TGF-b, resulting in three biological replicates for
each condition. The results were analyzed using Gene-
Spring software and the default statistical cutoffs. A
gene list was generated that contains genes that were
regulated either up or down by at least twofold with a
P-value < 0.05. There were 60 downregulated genes on
the list, and 65 genes were upregulated. A list of
selected genes is shown in Table 2. A full list of all the
regulated genes is given in Additional file 1. The list
includes several genes known to be regulated by TGF-
b, including proteoglycan 4/lubricin (PRG4) [32], para-
thyroid hormone-like hormone (PTHLH) [33], TGF-b-
induced protein IG-H3 (TGFBI) [34] and prostate
transmembrane protein, androgen-induced 1
(PMEPA1) [35], suggesting that the microarray was
effective in identifying TGF-b-regulated genes. Surpris-
ingly few genes encoding structural components of the
ECM were identified; however, several matrix-modify-
ing genes were upregulated, including 3’-phosphoade-
nosine 5’-phosphosulfate synthase 2 (PAPSS2),
procollagen lysine 2-oxoglutarate 5-dioxygenase 2
(PLOD2), Β-1,3-N-acetylgalactosaminyltransferase 2
(B3GALNT2), UDP-gal:bGlcNAcb1,3-galactosyltrans-
ferase polypeptide 2 (B3GALT2), glycosyltransferase 8
domain-containing 2 (GLT8D2), dermatan sulfate epi-
merase (DSE) and arylsulfatase family, member I
(ARSI). We also recently identified Papss2 as regulated
by TGF-b in a microarray screen of TGF-b-treated
mouse embryonic sclerotome [36]. This result sug-
gested that TGF-b may function to maintain articular
cartilage strength by regulating posttranslational modi-
fications in ECM proteins.
We verified regulation of several genes by TGF-b in
bovine articular cartilage micromass cultures using
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Figure 2 Mild osteoarthritis observed in dominant-negative transforming growth factor b type II receptor mice. Sections from 20-week-
old control (A), (C) and (E) and dominant-negative transforming growth factor b type II receptor (DNIIR) (B), (D) and (F) tibiae (n = 3 control
and 3 DNIIR) were stained with H & E (A) and (B), toluidine blue (C) and (D) and Sirius red/polarized light microscopy (E) and (F) to determine
the extent of osteoarthritis (n = 3 controls and 3 DNIIR). Fibrillation at the surface (B), focal cationic matrix stain depletion (D), cell clusters (D,
arrow and inset) and disorganized and increased collagen fibers (F, arrows) are shown.
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quantitative real-time RT-PCR (Figure 4A). Gene
expression was determined in cultures generated from
three separate cows, with each sample generated in tri-
plicate. Combined PCR data from the three biological
replicates were analyzed using REST software, which
normalizes results and calculates the relative fold differ-
ences in gene expression, confidence intervals and
statistical significance across experiments using an inte-
grated randomization and bootstrapping algorithm [30].
Bovine micromass cultures treated with TGF-b showed
significant upregulation of PRG4, a known target of
TGF-b (about 3.9-fold), PAPSS2 (about fivefold) and
PLOD2 (about 3.8-fold) relative to untreated controls,
thus verifying the microarray results.
Figure 3 Bovine articular chondrocytes in micromass culture. Bovine articular chondrocytes grown in micromass cultures were left untreated
(A) and (C) or treated with transforming growth factor b (TGF-b) (B) and (D) for 7 days. Cultures were stained for Alcian blue (A) and (B) or
alkaline phosphatase (C) and (D). Quantification of staining showed an increase in Alcian blue staining (E) and a decrease in alkaline
phosphatase activity after treatment with TGF-b (F). *P-value < 0.05 by t-test. pNP: p-nitophenol.
Table 2 Selected genes regulated by TGF-b in bovine articular chondrocytes
Probe set ID Gene name Gene symbol Fold difference Direction
TGF-b-regulated
4670.1.S1_at Transforming growth factor-b-induced protein IG-H3 TGFBI 10.44 Up
668.1.S1_at Prostate transmembrane protein, androgen-induced 1 PMEPA1 3.5 Up
22987.1.A1_at Proteoglycan 4/lubricin PRG4 2.11 Up
12848.1.S1_at Parathyroid hormone-like hormone PTHLH 4.12 Up
Matrix
568.1.S1_at Integrin-binding sialoprotein IBSP 4.48 Down
25236.1.A1_at Matrix-remodeling-associated 5 MXRA5 3.35 Up
Protein-modifying
28724.1.A1_a_at Arylsulfatase family, member I ARSI 3.88 Up
7447.1.A1_at UDP-gal:bGlcNAc b-1,3-galactosyltransferase, polypeptide 2 B3GALT2 2.43 Up
5086.2.S1_a_at b-1,3-N-acetylgalactosaminyltransferase 2 B3GALNT2 2.2 Up
17755.1.A1_at Dermatan sulfate epimerase DSE 2.53 Up
24824.1.S1_at Glycosyltransferase 8 domain-containing 2 GLT8D2 3.6 Down
1087.1.S1_at 3’-phosphoadenosine 5’-phosphosulfate synthase 2 PAPSS2 2.67 Up
25109.1.S1_at Procollagen lysine 2-oxoglutarate 5-dioxygenase 2 PLOD2 2.1 Up
Ramaswamy et al. Arthritis Research & Therapy 2012, 14:R49
http://arthritis-research.com/content/14/2/R49
Page 8 of 15
Figure 4 Papss2 is regulated by transforming growth factor b. (A) RNA isolated from bovine chondrocytes grown in micromass cultures and
either left untreated or treated with 5 ng/transforming growth factor b (TGF-b)/ml for 8 hours (n = 3 separate cows) was used in real-time RT-PCR.
Data are shown as tables obtained using REST software [30]. Papss2 and two other selected genes (Prg4 and Plod2) were upregulated after treatment
with TGF-b, confirming the microarray results. Gapdh was used as a normalization control. (B) Gene expression was compared by real-time RT-PCR
using RNA isolated from 20-week-old wild-type (WT) and dominant-negative TGF-b type II receptor (DNIIR) mice (n = 5 controls and 6 mutants) using
REST software. Significant downregulation of Prg4, Papss2 and Plod2 was seen in DNIIR samples. Hprt was used as a normalization control. Fxyd2 was
not regulated by TGF-b on the microarray, which we verified by RT-PCR. (C) Cell protein lysates were isolated from articular cartilage of 6-week-old, 20-
week-old and 10-month-old control and DNIIR mice (n = 3 each at age 6 weeks, 4 each at age at 20 weeks and 2 each at age 10 months). Papss2
expression was determined by Western blot analysis. Gapdh was used as a loading control. The average Papss2/Gapdh ratios derived from all of the
blots are shown, with the ratio for WT set to 1. Papss2 protein was reduced in DNIIR mice at each stage.
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Papss2 expression and sulfation of chondroitin are
reduced in DNIIR cartilage
Next, to determine if reduced TGF-b signaling in DNIIR
mice would alter expression of these genes in vivo,
quantitative real-time RT-PCR was performed as
described above with RNA from the articular cartilage
of 20-week-old DNIIR and WT mice (n = 5 WT and 6
DNIIR). Expression of DNIIR mRNA was confirmed in
each sample by semiquantitative RT-PCR (data not
shown). Downregulation of Prg4 (mean mRNA expres-
sion ratio of DNIIR/WT = 0.454), a known TGF-b-
responsive gene, was used to confirmed disruption of
TGF-b signaling in DNIIR cartilage (Figure 4B). Signifi-
cant downregulation of Papss2 (DNIIR/WT = 0.651)
and Plod2 (DNIIR/WT = 0.685) was observed in DNIIR
cartilage as compared to WT (Figure 4B). Fxyd2
encodes an ion transport regulator, which was used as
an unregulated control. The results suggest that TGF-b
signaling is required to maintain expression of these
genes in vivo.
Skeletal alterations in mice and humans with deficien-
cies in Papss2 have similarities to those of mice with
deficiencies in TGF-b signaling, including kyphosis,
postnatal short stature and progressive degeneration of
articular cartilage. Therefore, we decided to focus on
Papss2 [6,16-21,37]. To check whether reductions in
Papss2 mRNA translated to changes in protein levels,
we performed Western blot analysis using protein
lysates from cells isolated from articular cartilage of 6-
week-old, 20-week-old and 10-month-old mice. When
Papss2 levels in DNIIR mice were compared to those in
controls, the mutants exhibited close to a 50% reduction
in Papss2 protein levels at all ages tested (Figure 4C).
These results suggest that TGF-b is required to main-
tain protein levels of Papss2 in cartilage.
Alcian blue at specific molar concentrations of MgCl2
(0.5 M) and pH 5.8 has been shown to specifically stain
sulfated glycosaminoglycans with preference for chon-
droitin sulfate. This is known as critical electrolyte con-
centration (CEC) Alcian blue staining [25,26]. To
investigate whether DNIIR cartilage had alterations in
sulfation of glycosaminoglycans, we first compared CEC
Alcian blue staining in sections from 20-week-old WT
and DNIIR tibiae (n = 3 WT and 3 DNIIR) (Figures 5A
and 5B). In sections from WT mice, deep blue staining
could be seen in the pericellular matrix surrounding
cells as well as in the superficial layers of the cartilage.
Some blue staining was also observed in the interterri-
torial matrix of the deeper zones. In contrast, deep blue
staining was reduced or absent in the pericellular matrix
in DNIIR cartilage. In addition, staining appeared to be
reduced in the superficial zone.
To determine if the reduced staining was simply due
to lower levels of aggrecan core protein, we stained
separate sections from the same samples by immuno-
fluorescence using an anti-aggrecan core protein anti-
body (Figures 5C and 5D). In both controls and
mutants, staining could be seen at comparable levels in
both the pericellular and interterritorial matrix; there-
fore, the changes in CEC Alcian blue staining could not
be accounted for by alterations in aggrecan core protein
levels.
Next, we looked directly at C0S (Figures 5E and 5F)
and C4S (Figures 5G and 5H) using antibodies that
detect terminal unsaturated disaccharide sulfated in the
C-4 position of N-acetylhexosamine residue attached to
carbohydrate stub of the core protein after chondroiti-
nase treatment [38,39]. In wild-type cartilage, low levels
of diffuse C0S could be detected in the pericellular and
interterritorial matrix. In contrast, bright staining of C0S
was observed in cartilage from DNIIR mice. In control
cartilage, C4S staining was clearly detected in the peri-
cellular and interterritorial matrix; however, C4S stain-
ing was low in DNIIR cartilage, suggesting that reduced
sulfation in the matrix resulted in low levels of C4S and
correspondingly higher levels of C0S. This staining pat-
tern was previously observed in Papss2bm/bm-mutant
cartilage [40]. Together these results suggest a defect in
sulfation of the cartilage ECM that could result from
failure to maintain Papss2 expression in the absence of
TGF-b signaling.
Discussion
Several murine models with altered TGF-b signaling
in cartilage show signs of OA, but the biomechanical
properties of articular cartilage, which are critical for
its load-bearing ability, have not been studied in these
mice. Furthermore, the mechanisms by which altered
TGF-b signaling results in OA symptoms are not
known. Herein we show that articular cartilage from
DNIIR mice possess reduced stiffness at 20 weeks of
age, as indicated by stress-relaxation indentation tests
in comparison to WT mice. To address the function
of TGF-b in maintaining the cartilage phenotype, we
characterized global gene expression patterns in
bovine articular chondrocytes treated with TGF-b. We
identified several known TGF-b-responsive genes,
including PRG4, as well as genes important for post-
translational modifications of the ECM, including
PAPSS2 and PLOD2. Regulation of Papss2 mRNA and
protein in vivo was confirmed by comparing DNIIR
and WT mice. Downregulation of Papss2 in DNIIR
mice correlated with reduced critical electrolyte stain-
ing for Alcian blue and reduced C4S immunostaining.
Nevertheless, immunostaining for the aggrecan core
protein was comparable in control and DNIIR mice,
suggesting reduced matrix sulfation in the DNIIR
cartilage.
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Figure 5 Chondroitin-4-sulfate is reduced in DNIIR cartilage. Sections from wild-type (A), (C), (E) and (G) and dominant-negative
transforming growth factor b type II receptor (DNIIR) (B), (D), (F) and (H) tibiae (n = 3 controls and 3 DNIIR) were stained using Alcian blue at
critical electrolyte concentration (A) and (B) and immunofluorescence using anti-aggrecan (C) and (D) (green), anti-chondroitin-0-sulfate (E) and
(F) (red) and anti-chondroitin-4-sulfate (G) and (H) (red) antibodies. Alcian blue critical electrolyte staining and chondroitin-4-sulfate staining were
reduced in DNIIR cartilage, chondroitin-0-sulfate staining was increased and aggrecan staining was comparable to that of controls.
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The main function of articular cartilage is to act as a
cushion in diarthrodial joints by handling various
mechanical loads imparted on the joint through normal
activity. To characterize the changes in mechanical
properties in the DNIIR mutants, we performed a four-
step stress relaxation indentation test to measure instan-
taneous and equilibrium stiffness. Our tests revealed
that indentation stiffness is compromised in the DNIIR
cartilage, which would affect its load-bearing function.
Indentation stress relaxation tests similar to ours have
been employed previously to determine mechanical
properties of cartilage in mice with osteoarthritic
changes [10,22]. Cartilage consists of a solid (matrix),
fluid (water) and fixed-charge density, all of which con-
tribute to biomechanical properties of the tissue. Var-
ious methods have been used to describe the
biomechanical behavior of cartilage, including those that
take into account all the constituents of cartilage, in the
biphasic [41] and triphasic [42] models of cartilage
mechanics. These methods involve rigorous analytical
solutions that are beyond the scope of the current
study. Although our indentation technique does not
delineate the changes in each component of cartilage
separately, it still provides us with a structural parameter
with which to evaluate the differences in load-bearing
ability of articular cartilage.
Papss2 is one of the isoforms of the PAPS synthetase,
a bifunctional enzyme responsible for synthesis of PAPS,
the universal sulfate donor. Many of the phenotypes
observed in humans and mice with mutations in Papss2
overlap with those seen in mice with alterations in
TGF-b signaling [2,6,20]. Regulation of Papss1 and
Papss2 in the liver has been studied [43], but how
Papss2, which catalyzes the synthesis of PAPS for sulfa-
tion of glycosaminoglycans, is regulated in cartilage is
not known. Papss2 mRNA expression starts at 11.5 days
postcoitum in mouse cartilage as it condenses and con-
tinues in the newborn in all the cartilaginous elements
[44]. Interestingly, though its expression is significant in
condensing and proliferating chondrocytes, Papss2
mRNA is markedly reduced in hypertrophic chondro-
cytes. In addition, Papss2 mRNA expression overlaps
with that of Sox9, one of the master regulators of chon-
drogenesis. In this study, we have shown that TGF-b
treatment significantly increases PAPSS2 expression in
bovine chondrocyte cultures. Previously, we found that
TGF-b regulates Papss2 in mouse embryonic sclerotome
[36]. Furthermore, we found significant reduction in
Papss2 mRNA and protein levels in the articular carti-
lage of DNIIR mice, indicating an important role for
TGF-b in regulating this enzyme in vivo.
Because expression of DNIIR resulted in reduced
levels of Papss2, we hypothesized that the ECM in
DNIIR cartilage would be hyposulfated. We performed
Alcian blue staining using the critical electrolyte con-
centration principle. When we compared the staining
between the genotypes, DNIIR cartilage consistently
showed fainter staining, especially in the pericellular and
superficial zone matrix. Aggrecan core protein immu-
nostaining showed comparable expression, suggesting
the alterations in Alcian blue staining were due to
alterations in sulfation. To confirm alterations in sulfa-
tion more directly, we performed immunostaining for
C4S and C0S. These antibodies were used previously to
study sulfation of chondroitin in cartilage [40]. C4S
staining was reduced and C0S was increased, suggesting
that alterations in TGF-b signaling affect sulfation of
GAGs in the matrix. Negatively charged sulfate (SO3
-)
and carboxyl (COO-) groups help to retain water after
exudation caused by loading [13]. Changes in the sulfa-
tion of proteoglycans would be predicted to affect how
water is retained in the cartilage, which could in turn
alter mechanical properties. We hypothesize that altered
TGF-b signaling and subsequent downregulation of
Papss2 and matrix sulfation affect the biomechanical
properties of articular cartilage. It should be noted that
changes in Papss2 levels occur in DNIIR mice as early
as 6 weeks of age, long before changes in histological or
mechanical properties are observed. Turnover of the
ECM is very slow, so it is reasonable to propose that the
effects of downregulating Papss2 would take a long time
to manifest as changes in ECM sulfation or changes in
mechanical properties. This suggests TGF-b signaling
and regulation of Papss2 expression in mouse cartilage
are important in postnatal homeostasis of articular
cartilage.
Mutations in other genes of the sulfation cascade,
such as chondroitin-4-sulfotransferase 1 (Chst11) [45],
diastropic dysplasia transporter (Dtdst or Slc26a2)
[46,47] and extracellular heparan endosulfatases (Sulf-1
and Sulf-2) [48], have also been shown to result in var-
ious types of chondrodysplasias, some of which are
lethal (mutations in Dtdst: achondrogenesis type IB
[OMIM:600972]; atelosteogenesis type 2
[OMIM:256050]). Chst11 was recently identified as a
target of bone morphogenetic protein (BMP) signaling
and also was found to contain cis-regulatory modules
that potentially could respond to TGF-b. We did not
identify changes in expression of CHST11 or any other
sulfotransferase in bovine articular chondrocytes in
response to TGF-b in our microarray experiments,
although several are spotted on the array and are anno-
tated in the bovine genome. There are some overlapping
embryonic phenotypes in the skeletons of mice with
conditional deletion of Tgfbr2 [2,20] and mutation in
Chst11, including misshapen vertebrae and failure of the
joints to form in the digits; however, the phenotype of
the growth plate in Chst11 mutants was distinct from
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that seen in mice with loss of TGF-b signaling and may
be due to secondary effects on patterning of both BMP
and TGF-b signals. Postnatal maintenance of the articu-
lar cartilage was not characterized in mice with a muta-
tion in Chst11.
Plod2, a lysyl hydroxylase important for cross-linking
collagen, was also regulated by TGF-b. Mutations in
PLOD2 have been associated with the clinical condition
Bruck syndrome 2 [OMIM:609220], which is character-
ized by abnormal collagen cross-linking in bone, osteo-
penia and multiple fractures in mice. Unlike mutations
in PAPSS2, mutations in PLOD2 appear to affect bone
structure more than cartilage [49,50], although a role in
TGF-b-mediated chondroprotection is still possible.
Whether alterations in Plod2 expression translate to
defective cross-linking of type II collagen and alterations
in mechanical properties in DNIIR mice was not
addressed in this study; however, Sirius Red staining and
polarized light microscopy indicated disorganization of
collagen fibers in the articular cartilage of DNIIR mice
compared to WT controls.
Prg4, a secreted glycoprotein, which is already known
to be positively regulated by TGF-b in superficial zone
chondrocytes [32] and has a protective effect on carti-
lage surfaces, was downregulated in the DNIIR mutants
at the mRNA level. Prg4-knockout mice develop joint
disease with age-associated increased joint friction and
reduced mechanical properties of the cartilage [51,52].
Decreased Prg4 expression in the DNIIR mutants may
also contribute to the reduction in mechanical proper-
ties observed.
Conclusions
In conclusion, TGF-b signaling is required for the bio-
mechanical integrity of articular cartilage. TGF-b upre-
gulates the expression of several matrix-modifying
enzymes, including Papss2, which mediates the rate-lim-
iting step of protein sulfation. Tgfbr2 is required to
maintain Papss2 mRNA and protein expression in vivo
as well as sulfation levels in the cartilage ECM.
Additional material
Additional file 1: Genes regulated by TGF-b (P < 0.05), up- or
downregulated. Excel file.
Abbreviations
BSA: bovine serum albumin; C0S: chondroitin-0-sulfate; C4S: chondroitin-4-
sulfate; DMEM: Dulbecco’s modified Eagle’s medium; DNIIR: dominant-
negative transforming growth factor β type II receptor; ECM: extracellular
matrix; Gapdh: glyceraldehyde 3-phosphate dehydrogenase; H & E:
hematoxylin and eosin; Hprt: hypoxanthine-guanine
phosphoribosyltransferase; LTBP3: latent transforming growth factor β-
binding protein 3; Papss2: phosphoadenosine phosphosulfate synthetase 2;
PBS: phosphate-buffered saline; PCR: polymerase chain reaction; Plod2:
procollagen lysine 2-oxoglutarate 5-dioxygenase 2; Prg4: proteoglycan 4; RT:
reverse transcriptase; TGF-β: transforming growth factor β; Tgfbr2:
transforming growth factor β type II receptor.
Acknowledgements
We thank Drs Michael Crowley and David Crossman at the UAB Heflin
Center Genomics Core Facility for help with microarrays and analysis. We
also acknowledge the Biomechanics Core in the UAB Department of
Biomedical Engineering. We express our deep appreciation for helpful
discussion with Dr Anne Woods of the UAB Department of Cell Biology. This
work was supported by National Institute of Arthritis and Musculoskeletal
and Skin Diseases grants AR-055110 and AR-053860 (to RS).
Author details
1Department of Biomedical Engineering, University of Alabama at
Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294-1150, USA.
2Department of Cell Biology, University of Alabama at Birmingham, 1530 3rd
Avenue South, Birmingham, AL 35294-0005, USA.
Authors’ contributions
GR carried out the indentation studies, confirmation of the microarray results
and characterization of Papss2 expression and sulfation in wild-type and
mutant mice. He also participated in planning the experiments, interpreting
the results and writing the manuscript. PS set up the bovine cartilage
micromass cultures and carried out the microarray studies. AE helped with
the design and interpretation of the indentation studies. RS conceived the
study and participated in its design and coordination. She also participated
in interpretation of the data and the final writing of the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 10 October 2011 Revised: 9 February 2012
Accepted: 6 March 2012 Published: 6 March 2012
References
1. Goldring MB, Goldring SR: Osteoarthritis. J Cell Physiol 2007, 213:626-634.
2. Seo HS, Serra R: Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme
results in defects in development of the long bones and joints. Dev Biol
2007, 310:304-316.
3. van der Kraan PM, Blaney Davidson EN, van den Berg WB: A role for age-
related changes in TGFβ signaling in aberrant chondrocyte
differentiation and osteoarthritis. Arthritis Res Ther 2010, 12:201.
4. Verdier MP, Seité S, Guntzer K, Pujol JP, Boumédiène K:
Immunohistochemical analysis of transforming growth factor β isoforms
and their receptors in human cartilage from normal and osteoarthritic
femoral heads. Rheumatol Int 2005, 25:118-124.
5. Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB,
Goumans MJ, van den Berg WB, van der Kraan PM: Increase in ALK1/ALK5
ratio as a cause for elevated MMP-13 expression in osteoarthritis in
humans and mice. J Immunol 2009, 182:7937-7945.
6. Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R,
Moses HL: Expression of a truncated, kinase-defective TGF-β type II
receptor in mouse skeletal tissue promotes terminal chondrocyte
differentiation and osteoarthritis. J Cell Biol 1997, 139:541-552.
7. Yang X, Chen L, Xu X, Li C, Huang C, Deng CX: TGF-β/Smad3 signals
repress chondrocyte hypertrophic differentiation and are required for
maintaining articular cartilage. J Cell Biol 2001, 153:35-46.
8. Dabovic B, Chen Y, Colarossi C, Zambuto L, Obata H, Rifkin DB: Bone
defects in latent TGF-β binding protein (Ltbp)-3 null mice: a role for
Ltbp in TGF-β presentation. J Endocrinol 2002, 175:129-141.
9. Wu Q, Kim KO, Sampson ER, Chen D, Awad H, O’Brien T, Puzas JE, Drissi H,
Schwarz EM, O’Keefe RJ, Zuscik MJ, Rosier RN: Induction of an
osteoarthritis-like phenotype and degradation of phosphorylated Smad3
by Smurf2 in transgenic mice. Arthritis Rheum 2008, 58:3132-3144.
10. Alexopoulos LG, Youn I, Bonaldo P, Guilak F: Developmental and
osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI
collagen in the cartilage pericellular matrix. Arthritis Rheum 2009,
60:771-779.
Ramaswamy et al. Arthritis Research & Therapy 2012, 14:R49
http://arthritis-research.com/content/14/2/R49
Page 13 of 15
11. Knecht S, Vanwanseele B, Stussi E: A review on the mechanical quality of
articular cartilage: implications for the diagnosis of osteoarthritis. Clin
Biomech (Bristol, Avon) 2006, 21:999-1012.
12. Le NA, Fleming BC: Measuring fixed charge density of goat articular
cartilage using indentation methods and biochemical analysis. J Biomech
2008, 41:715-720.
13. Lu XL, Mow VC: Biomechanics of articular cartilage and determination of
material properties. Med Sci Sports Exerc 2008, 40:193-199.
14. Venkatachalam KV: Human 3’-phosphoadenosine 5’-phosphosulfate
(PAPS) synthase: biochemistry, molecular biology and genetic deficiency.
IUBMB Life 2003, 55:1-11.
15. Prydz K, Dalen KT: Synthesis and sorting of proteoglycans. J Cell Sci 2000,
113:193-205.
16. Ahmad M, Haque MF, Ahmad W, Abbas H, Haque S, Krakow D, Rimoin DL,
Lachman RS, Cohn DH: Distinct, autosomal recessive form of
spondyloepimetaphyseal dysplasia segregating in an inbred Pakistani
kindred. Am J Med Genet 1998, 78:468-473.
17. Faiyaz ul Haque M, King LM, Krakow D, Cantor RM, Rusiniak ME, Swank RT,
Superti-Furga A, Haque S, Abbas H, Ahmad W, Ahmad M, Cohn DH:
Mutations in orthologous genes in human spondyloepimetaphyseal
dysplasia and the brachymorphic mouse. Nat Genet 1998, 20:157-162.
18. Kurima K, Warman ML, Krishnan S, Domowicz M, Krueger RC Jr, Deyrup A,
Schwartz NB: A member of a family of sulfate-activating enzymes causes
murine brachymorphism. Proc Natl Acad Sci USA 1998, 95:8681-8685.
19. Ford-Hutchinson AF, Ali Z, Seerattan RA, Cooper DM, Hallgrímsson B,
Salo PT, Jirik FR: Degenerative knee joint disease in mice lacking 3’-
phosphoadenosine 5’-phosphosulfate synthetase 2 (Papss2) activity: a
putative model of human PAPSS2 deficiency-associated arthrosis.
Osteoarthritis Cartilage 2005, 13:418-425.
20. Baffi MO, Slattery E, Sohn P, Moses HL, Chytil A, Serra R: Conditional
deletion of the TGF-β type II receptor in Col2a expressing cells results in
defects in the axial skeleton without alterations in chondrocyte
differentiation or embryonic development of long bones. Dev Biol 2004,
276:124-142.
21. Sugahara K, Schwartz NB: Defect in 3’-phosphoadenosine 5’-
phosphosulfate synthesis in brachymorphic mice. II. Tissue distribution
of the defect. Arch Biochem Biophys 1982, 214:602-609.
22. Hyttinen MM, Töyräs J, Lapveteläinen T, Lindblom J, Prockop DJ, Li SW,
Arita M, Jurvelin JS, Helminen HJ: Inactivation of one allele of the type II
collagen gene alters the collagen network in murine articular cartilage
and makes cartilage softer. Ann Rheum Dis 2001, 60:262-268.
23. Roemhildt ML, Coughlin KM, Peura GD, Fleming BC, Beynnon BD: Material
properties of articular cartilage in the rabbit tibial plateau. J Biomech
2006, 39:2331-2337.
24. IHC World: Life Science Information Network. [http://www.ihcworld.com/].
25. Scott JE, Dorling J: Differential staining of acid glycosaminoglycans
(mucopolysaccharides) by alcian blue in salt solutions. Histochemie 1965,
5:221-233.
26. Taylor JR, Scott JE, Cribb AM, Bosworth TR: Human intervertebral disc acid
glycosaminoglycans. J Anat 1992, 180:137-141.
27. Chen P, Vukicevic S, Sampath TK, Luyten FP: Bovine articular chondrocytes
do not undergo hypertrophy when cultured in the presence of serum
and osteogenic protein-1. Biochem Biophys Res Commun 1993,
197:1253-1259.
28. Luyten FP, Chen P, Paralkar V, Reddi AH: Recombinant bone
morphogenetic protein-4, transforming growth factor-β1, and activin A
enhance the cartilage phenotype of articular chondrocytes in vitro. Exp
Cell Res 1994, 210:224-229.
29. Björnsson S: Simultaneous preparation and quantitation of proteoglycans
by precipitation with alcian blue. Anal Biochem 1993, 210:282-291.
30. Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool
(REST) for group-wise comparison and statistical analysis of relative
expression results in real-time PCR. Nucleic Acids Res 2002, 30:e36.
31. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D,
van den Berg WB: Osteoarthritis cartilage histopathology: grading and
staging. Osteoarthritis Cartilage 2006, 14:13-29.
32. Niikura T, Reddi AH: Differential regulation of lubricin/superficial zone
protein by transforming growth factor β/bone morphogenetic protein
superfamily members in articular chondrocytes and synoviocytes.
Arthritis Rheum 2007, 56:2312-2321.
33. Alvarez J, Sohn P, Zeng X, Doetschman T, Robbins DJ, Serra R: TGFβ2
mediates the effects of Hedgehog on hypertrophic differentiation and
PTHrP expression. Development 2002, 129:1913-1924.
34. Ohno S, Tanaka N, Ueki M, Honda K, Tanimoto K, Yoneno K, Ohno-
Nakahara M, Fujimoto K, Kato Y, Tanne K: Mechanical regulation of
terminal chondrocyte differentiation via RGD-CAP/βig-h3 induced by
TGF-β. Connect Tissue Res 2005, 46:227-234.
35. Brunschwig EB, Wilson K, Mack D, Dawson D, Lawrence E, Willson JK, Lu S,
Nosrati A, Rerko RM, Swinler S, Beard L, Lutterbaugh JD, Willis J, Platzer P,
Markowitz S: PMEPA1, a transforming growth factor-β-induced marker of
terminal colonocyte differentiation whose expression is maintained in
primary and metastatic colon cancer. Cancer Res 2003, 63:1568-1575.
36. Sohn P, Cox M, Chen D, Serra R: Molecular profiling of the developing
mouse axial skeleton: a role for Tgfbr2 in the development of the
intervertebral disc. BMC Dev Biol 2010, 10:29.
37. Sugahara K, Schwartz NB: Defect in 3’-phosphoadenosine 5’-
phosphosulfate synthesis in brachymorphic mice: I. Characterization of
the defect. Arch Biochem Biophys 1982, 214:589-601.
38. Couchman JR, Caterson B, Christner JE, Baker JR: Mapping by monoclonal
antibody detection of glycosaminoglycans in connective tissues. Nature
1984, 307:650-652.
39. Caterson B, Christner JE, Baker JR, Couchman JR: Production and
characterization of monoclonal antibodies directed against connective
tissue proteoglycans. Fed Proc 1985, 44:386-393.
40. Cortes M, Baria AT, Schwartz NB: Sulfation of chondroitin sulfate
proteoglycans is necessary for proper Indian hedgehog signaling in the
developing growth plate. Development 2009, 136:1697-1706.
41. Mak AF, Lai WM, Mow VC: Biphasic indentation of articular cartilage: I.
Theoretical analysis. J Biomech 1987, 20:703-714.
42. Lu XL, Miller C, Chen FH, Guo XE, Mow VC: The generalized triphasic
correspondence principle for simultaneous determination of the
mechanical properties and proteoglycan content of articular cartilage by
indentation. J Biomech 2007, 40:2434-2441.
43. Alnouti Y, Klaassen CD: Regulation of sulfotransferase enzymes by
prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther
2008, 324:612-621.
44. Stelzer C, Brimmer A, Hermanns P, Zabel B, Dietz UH: Expression profile of
Papss2 (3’-phosphoadenosine 5’-phosphosulfate synthase 2) during
cartilage formation and skeletal development in the mouse embryo. Dev
Dyn 2007, 236:1313-1318.
45. Klüppel M, Wight TN, Chan C, Hinek A, Wrana JL: Maintenance of
chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is
required for chondrocyte development and growth factor signaling
during cartilage morphogenesis. Development 2005, 132:3989-4003.
46. Bonafé L, Hästbacka J, de la Chapelle A, Campos-Xavier AB, Chiesa C,
Forlino A, Superti-Furga A, Rossi A: A novel mutation in the sulfate
transporter gene SLC26A2 (DTDST) specific to the Finnish population
causes de la Chapelle dysplasia. J Med Genet 2008, 45:827-831.
47. Forlino A, Piazza R, Tiveron C, Della Torre S, Tatangelo L, Bonafé L,
Gualeni B, Romano A, Pecora F, Superti-Furga A, Cetta G, Rossi A: A
diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse:
morphological and biochemical characterization of the resulting
chondrodysplasia phenotype. Hum Mol Genet 2005, 14:859-871.
48. Otsuki S, Hanson SR, Miyaki S, Grogan SP, Kinoshita M, Asahara H,
Wong CH, Lotz MK: Extracellular sulfatases support cartilage homeostasis
by regulating BMP and FGF signaling pathways. Proc Natl Acad Sci USA
2010, 107:10202-10207.
49. Bank RA, Robins SP, Wijmenga C, Breslau-Siderius LJ, Bardoel AF, van der
Sluijs HA, Pruijs HE, TeKoppele JM: Defective collagen crosslinking in
bone, but not in ligament or cartilage, in Bruck syndrome: indications
for a bone-specific telopeptide lysyl hydroxylase on chromosome 17.
Proc Natl Acad Sci USA 1999, 96:1054-1058.
50. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE,
Sillence DO, Brinckmann J, Abraham DJ, Black CM, Verzijl N, DeGroot J,
Hanemaaijer R, TeKoppele JM, Huizinga TW, Bank RA: Identification of
PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis.
J Biol Chem 2003, 278:40967-40972.
51. Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD,
Stewart M, Wang H, Warman ML, Carpten JD: The secreted glycoprotein
lubricin protects cartilage surfaces and inhibits synovial cell overgrowth.
J Clin Invest 2005, 115:622-631.
Ramaswamy et al. Arthritis Research & Therapy 2012, 14:R49
http://arthritis-research.com/content/14/2/R49
Page 14 of 15
52. Coles JM, Zhang L, Blum JJ, Warman ML, Jay GD, Guilak F, Zauscher S: Loss
of cartilage structure, stiffness, and frictional properties in mice lacking
PRG4. Arthritis Rheum 2010, 62:1666-1674.
doi:10.1186/ar3762
Cite this article as: Ramaswamy et al.: Altered responsiveness to TGF-b
results in reduced Papss2 expression and alterations in the
biomechanical properties of mouse articular cartilage. Arthritis Research &
Therapy 2012 14:R49.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ramaswamy et al. Arthritis Research & Therapy 2012, 14:R49
http://arthritis-research.com/content/14/2/R49
Page 15 of 15
